Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients

Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients

BackgroundPSMA PET is frequently used for staging of prostate cancer patients. Furthermore, there is increasing interest to use PET information for personalized local treatment approaches in surgery and radiotherapy, especially for focal treatment strategies. However, it is not well established whic...

Full description

Bibliographic Details
Main Authors: Sebastian Zschaeck, Stephanie Bela Andela, Holger Amthauer, Christian Furth, Julian M. Rogasch, Marcus Beck, Frank Hofheinz, Kai Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
PSMA
prostate specific membrane antigen
positron emission tomography
primary prostate cancer
quantitative PET parameters
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.879089/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.879089/full

Similar Items